MeiHua Holdings GroupLtd Full Year 2024 Earnings: Misses Expectations
MeiHua Holdings GroupLtd (SHSE:600873) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥25.1b (down 9.7% from FY 2023).
- Net income: CN¥2.74b (down 14% from FY 2023).
- Profit margin: 11% (in line with FY 2023).
- EPS: CN¥0.94 (down from CN¥1.06 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
MeiHua Holdings GroupLtd Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 12%.
Looking ahead, revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
Performance of the Chinese Chemicals industry.
The company's shares are up 4.6% from a week ago.
Valuation
Our analysis of these results suggests MeiHua Holdings GroupLtd may be undervalued based on 6 important criteria we look at. Discover what analysts are forecasting and how the current share price shapes up by clicking here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:600873
MeiHua Holdings GroupLtd
A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.
Very undervalued with flawless balance sheet and pays a dividend.